These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 11912250

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
    Ostendorf T, van Roeyen CR, Peterson JD, Kunter U, Eitner F, Hamad AJ, Chan G, Jia XC, Macaluso J, Gazit-Bornstein G, Keyt BA, Lichenstein HS, LaRochelle WJ, Floege J.
    J Am Soc Nephrol; 2003 Sep; 14(9):2237-47. PubMed ID: 12937299
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases.
    Eitner F, Ostendorf T, Kretzler M, Cohen CD, Eriksson U, Gröne HJ, Floege J, ERCB-Consortium.
    J Am Soc Nephrol; 2003 May; 14(5):1145-53. PubMed ID: 12707385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ.
    Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
    [Abstract] [Full Text] [Related]

  • 8. Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis.
    Sawai K, Mori K, Mukoyama M, Sugawara A, Suganami T, Koshikawa M, Yahata K, Makino H, Nagae T, Fujinaga Y, Yokoi H, Yoshioka T, Yoshimoto A, Tanaka I, Nakao K.
    J Am Soc Nephrol; 2003 May; 14(5):1154-63. PubMed ID: 12707386
    [Abstract] [Full Text] [Related]

  • 9. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
    Yoshimura A, Inui K, Nemoto T, Uda S, Sugenoya Y, Watanabe S, Yokota N, Taira T, Iwasaki S, Ideura T.
    J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
    [Abstract] [Full Text] [Related]

  • 10. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis.
    Bessho K, Mizuno S, Matsumoto K, Nakamura T.
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276
    [Abstract] [Full Text] [Related]

  • 11. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
    Floege J, Eng E, Young BA, Couser WG, Johnson RJ.
    Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
    [Abstract] [Full Text] [Related]

  • 12. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.
    Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ.
    J Clin Invest; 1993 Dec; 92(6):2952-62. PubMed ID: 7902849
    [Abstract] [Full Text] [Related]

  • 13. Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease.
    van Roeyen CR, Eitner F, Martinkus S, Thieltges SR, Ostendorf T, Bokemeyer D, Lüscher B, Lüscher-Firzlaff JM, Floege J, Mertens PR.
    J Am Soc Nephrol; 2005 Oct; 16(10):2985-96. PubMed ID: 16093451
    [Abstract] [Full Text] [Related]

  • 14. Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis.
    Tamai O, Oka N, Kikuchi T, Koda Y, Soejima M, Wada Y, Fujisawa M, Tamaki K, Kawachi H, Shimizu F, Kimura H, Imaizumi T, Okuda S.
    Kidney Int; 2001 Feb; 59(2):471-80. PubMed ID: 11168929
    [Abstract] [Full Text] [Related]

  • 15. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat.
    Iida H, Seifert R, Alpers CE, Gronwald RG, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF.
    Proc Natl Acad Sci U S A; 1991 Aug 01; 88(15):6560-4. PubMed ID: 1713682
    [Abstract] [Full Text] [Related]

  • 16. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A, Nemoto T, Sugenoya Y, Inui K, Watanabe S, Inoue Y, Sharif S, Yokota N, Uda S, Morita H, Ideura T.
    Kidney Int Suppl; 1999 Jul 01; 71():S84-7. PubMed ID: 10412745
    [Abstract] [Full Text] [Related]

  • 17. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.
    Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janjić N.
    Am J Pathol; 1999 Jan 01; 154(1):169-79. PubMed ID: 9916931
    [Abstract] [Full Text] [Related]

  • 18. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization.
    Yoshimura A, Gordon K, Alpers CE, Floege J, Pritzl P, Ross R, Couser WG, Bowen-Pope DF, Johnson RJ.
    Kidney Int; 1991 Sep 01; 40(3):470-6. PubMed ID: 1724021
    [Abstract] [Full Text] [Related]

  • 19. Smooth-muscle calponin in mesangial cells: regulation of expression and a role in suppressing glomerulonephritis.
    Sugenoya Y, Yoshimura A, Yamamura H, Inui K, Morita H, Yamabe H, Ueki N, Ideura T, Takahashi K.
    J Am Soc Nephrol; 2002 Feb 01; 13(2):322-331. PubMed ID: 11805159
    [Abstract] [Full Text] [Related]

  • 20. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
    Ostendorf T, Rong S, Boor P, Wiedemann S, Kunter U, Haubold U, van Roeyen CR, Eitner F, Kawachi H, Starling G, Alvarez E, Smithson G, Floege J.
    J Am Soc Nephrol; 2006 Apr 01; 17(4):1054-62. PubMed ID: 16510766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.